Xtant Medical Holdings Inc  

(Public, OTCMKTS:BONE)   Watch this stock  
Find more results for NYSEAMEX:BONE
3.55
-0.21 (-5.59%)
Sep 1 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 3.52 - 4.00
52 week 2.19 - 5.71
Open 3.78
Vol / Avg. 5,944.00/14,557.00
Mkt cap 41.70M
P/E     -
Div/yield     -
EPS -1.71
Shares 11.75M
Beta 1.81
Inst. own 7%
Nov 3, 2015
Q3 2015 Bacterin International Holdings Inc Earnings Release (Estimated) Add to calendar
Sep 9, 2015
Xtant Medical Holdings Inc at Rodman & Renshaw Global Investment Conference - 12:05PM EDT - Add to calendar
Aug 13, 2015
Q2 2015 Xtant Medical Holdings Inc Earnings Call
Aug 12, 2015
Q2 2015 Xtant Medical Holdings Inc Earnings Release
Jul 28, 2015
Bacterin International Holdings Inc to Purchase the Outstanding Common Stock of X-spine Systems, Inc., Creating Xtant Medical - Webcast
Jun 24, 2015
Bacterin International Holdings Inc Annual Shareholders Meeting
  

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -29.27% -29.74%
Operating margin -13.98% -17.73%
EBITD margin - -12.45%
Return on average assets -43.22% -36.98%
Return on average equity - -
Employees 150 -
CDP Score - -

Address

664 Cruiser Ln
BELGRADE, MT 59714-9719
United States - Map
+1-406-3880480 (Phone)
+1-302-6365454 (Fax)

Website links

Description

Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., is engaged in developing, manufacturing and marketing biologics products to domestic and international markets. The Company's bone graft products are used in a range of applications, including enhancing fusion in spine surgery, relief of back pain through facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries. The Company's acellular dermis scaffolds are utilized in wound care and plastic, as well as reconstructive procedures. The Company's portfolio of biologics products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoWrap, OsteoLock, BacFast HD, OsteoSTX, hMatrix, Sports Med and its line of 3Demin products, as well as other allograft products. In addition, the Company provides hardware products, including Axle, IRIX-C, Calix, Xpress and Silex.

Officers and directors

Kent L. Swanson Independent Chairman of the Board
Age: 70
Robert Di Silvio President
Age: 61
Daniel S. Goldberger Chief Executive Officer, Director
Age: 56
John P. Gandolfo Chief Financial Officer
Age: 54
Darrel Lee Holmes Chief Operating Officer
Age: 62
Gregory Juda Ph.D. Chief Scientific Officer
Age: 39
John Deedrick Independent Director
Age: 52
David E. Goodman M.D. Independent Director
Age: 59
Michael A. Lopach CPA Independent Director
Age: 66
Jon M. Wickwire Independent Director
Age: 71